GS101 injection

DRUG2 trials

Sponsors

Jiangsu Genscend Biopharmaceutical Co., Ltd

Conditions

Atopic Dermatitis (AD)

Phase 1

A Phase 1 Clinical Study Comparing GS101 and Dupixent® After Subcutaneous Injection

RecruitingNCT07411755

Jiangsu Genscend Biopharmaceutical Co., LtdAtopic Dermatitis (AD)

Start: 2026-03-05End: 2026-09-01Target: 294Updated: 2026-05-20

Phase 3

A Phase III Study of GS101 Injection to Dupixent®

Not yet recruitingNCT07386743

Jiangsu Genscend Biopharmaceutical Co., LtdAtopic Dermatitis (AD)

Start: 2026-02-01End: 2028-01-01Target: 572Updated: 2026-02-04